---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-006402"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2022-03-09T23:59:59+00:00"
generated_at: "2026-06-27T00:25:05.205357+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics appoints Jeremy Ferrell as CFO, effective March 9, 2022

## Summary
- Jeremy Ferrell (CPA, MBA) appointed CFO; base salary $250,000/year, annual bonus up to 40%.
- Stock options for up to 600,000 shares at grant date market price; 25% vest at grant, rest over 3 years.
- Employment agreement is indefinite duration, at-will; includes standard terms.
- Ferrell has 25+ years finance experience; most recently CFO at Miku, Inc.

## SEC filing metadata
- accession: 0001493152-22-006402
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2022-03-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315222006402/0001493152-22-006402-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315222006402/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-006402
- JSON: https://secwatch.observer/filing/0001493152-22-006402.json
- Plain text: https://secwatch.observer/filing/0001493152-22-006402.txt

## Key facts
- Executive change
  Jeremy Ferrell was appointed as Chief Financial Officer at Sigyn Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: The Board of Directors of Sigyn Therapeutics, Inc. (“the Company”) appointed Jeremy Ferrell, CPA, MBA as Chief Financial Officer (“CFO”), effective March 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642159/000149315222006402/0001493152-22-006402-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.